Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1676 (LINC01676) is a non-coding RNA gene that encodes a transcript longer than 200 nucleotides and does not overlap any protein-coding region. LINC01676 belongs to the class of lincRNAs, which are involved in modulation of chromatin structure, regulation of gene expression, and fine-tuning of transcriptional programs with tissue specificity. Its molecular function is presumed to be regulatory, typical of lincRNAs, but precise roles for LINC01676 remain uncharacterized in current literature. There is no evidence of direct drug interaction or use as a biomarker, and the molecule is not considered a classical therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1676 (LINC01676).